Cargando…

Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis

Sodium butyrate (SoB) supplementation has been suggested to attenuate the development of non-alcoholic fatty liver disease (NAFLD). Here, we determined the therapeutic potential of SoB on NAFLD progression and molecular mechanism involved. Eight-week old C57BL/6J mice were pair-fed a fat-, fructose-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baumann, Anja, Jin, Cheng Jun, Brandt, Annette, Sellmann, Cathrin, Nier, Anika, Burkard, Markus, Venturelli, Sascha, Bergheim, Ina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231312/ https://www.ncbi.nlm.nih.gov/pubmed/32235497 http://dx.doi.org/10.3390/nu12040951

Ejemplares similares

Oral arginine supplementation protects female mice from the onset of non-alcoholic steatohepatitis
por: Sellmann, Cathrin, et al.
Publicado: (2017)

Citrulline supplementation attenuates the development of non-alcoholic steatohepatitis in female mice through mechanisms involving intestinal arginase
por: Rajcic, Dragana, et al.
Publicado: (2021)

Fortifying Butterfat with Soybean Oil Attenuates the Onset of Diet-Induced Non-Alcoholic Steatohepatitis and Glucose Intolerance
por: Sánchez, Victor, et al.
Publicado: (2021)

Consumption of decaffeinated coffee protects against the development of early non-alcoholic steatohepatitis: Role of intestinal barrier function
por: Brandt, Annette, et al.
Publicado: (2018)

Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine
por: Brandt, Annette, et al.
Publicado: (2019)

Metabolic Abnormalities in Normal Weight Children Are Associated with Increased Visceral Fat Accumulation, Elevated Plasma Endotoxin Levels and a Higher Monosaccharide Intake
por: Nier, Anika, et al.
Publicado: (2019)

Non-Alcoholic Fatty Liver Disease in Overweight Children: Role of Fructose Intake and Dietary Pattern
por: Nier, Anika, et al.
Publicado: (2018)

Beneficial Effects of Vitamin D Treatment in an Obese Mouse Model of Non-Alcoholic Steatohepatitis
por: Jahn, Daniel, et al.
Publicado: (2019)

Alterations of nitric oxide homeostasis as trigger of intestinal barrier dysfunction in non‐alcoholic fatty liver disease
por: Baumann, Anja, et al.
Publicado: (2022)

Exchanging dietary fat source with extra virgin olive oil does not prevent progression of diet-induced non-alcoholic fatty liver disease and insulin resistance
por: Rajcic, Dragana, et al.
Publicado: (2020)

Short‐Term Isocaloric Intake of a Fructose‐ but not Glucose‐Rich Diet Affects Bacterial Endotoxin Concentrations and Markers of Metabolic Health in Normal Weight Healthy Subjects
por: Nier, Anika, et al.
Publicado: (2019)

Toll-like receptor 1 as a possible target in non-alcoholic fatty liver disease
por: Baumann, Anja, et al.
Publicado: (2021)

Markers of intestinal permeability are already altered in early stages of non-alcoholic fatty liver disease: Studies in children
por: Nier, Anika, et al.
Publicado: (2017)

Short-Term Intake of a Fructose-, Fat- and Cholesterol-Rich Diet Causes Hepatic Steatosis in Mice: Effect of Antibiotic Treatment
por: Brandt, Annette, et al.
Publicado: (2017)

Supplementing L-Citrulline Can Extend Lifespan in C. elegans and Attenuate the Development of Aging-Related Impairments of Glucose Tolerance and Intestinal Barrier in Mice
por: Rajcic, Dragana, et al.
Publicado: (2023)

Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Nier, Anika, et al.
Publicado: (2020)

Impairments of intestinal arginine and NO metabolisms trigger aging-associated intestinal barrier dysfunction and ‘inflammaging'
por: Brandt, Annette, et al.
Publicado: (2022)

Markers of Intestinal Permeability Are Rapidly Improved by Alcohol Withdrawal in Patients with Alcohol-Related Liver Disease
por: Jung, Finn, et al.
Publicado: (2021)

Sodium butyrate reduces high-fat diet-induced non-alcoholic steatohepatitis through upregulation of hepatic GLP-1R expression
por: Zhou, Da, et al.
Publicado: (2018)

TNFα is a key trigger of inflammation in diet-induced non-obese MASLD in mice
por: Burger, Katharina, et al.
Publicado: (2023)

Oral intake of xanthohumol attenuates lipoteichoic acid-induced inflammatory response in human PBMCs
por: Jung, Finn, et al.
Publicado: (2022)

Effects of quercetin and coated sodium butyrate dietary supplementation in diquat-challenged pullets
por: Zhou, Ning, et al.
Publicado: (2022)

HDAC Inhibitor Sodium Butyrate Attenuates the DNA Repair in Transformed but Not in Normal Fibroblasts
por: Gnedina, Olga O., et al.
Publicado: (2022)

Sodium Butyrate Attenuated Diabetes-Induced Intestinal Inflammation by Modulating Gut Microbiota
por: Liu, Liping, et al.
Publicado: (2022)

The Effects of Sodium Butyrate, Coated Sodium Butyrate, and Butyric Acid Glycerides on Nutrient Digestibility, Gastrointestinal Function, and Fecal Microbiota in Turkeys
por: Makowski, Zbigniew, et al.
Publicado: (2022)

Fructose: a modulator of intestinal barrier function and hepatic health?
por: Staltner, Raphaela, et al.
Publicado: (2023)

Acute Intake of Sucrose but Not of the Intense Sweetener Sucralose Is Associated with Post-Prandial Endotoxemia in Healthy Young Adults—A Randomized Controlled Trial
por: Staltner, Raphaela, et al.
Publicado: (2023)

Butyrate Protects Mice Against Methionine–Choline-Deficient Diet-Induced Non-alcoholic Steatohepatitis by Improving Gut Barrier Function, Attenuating Inflammation and Reducing Endotoxin Levels
por: Ye, Jianzhong, et al.
Publicado: (2018)

Ipragliflozin attenuates non-alcoholic steatohepatitis development in an animal model
por: Morishita, Asahiro, et al.
Publicado: (2022)

Regulation of hepatic genes related to lipid metabolism and antioxidant enzymes by sodium butyrate supplementation
por: Honma, Kazue, et al.
Publicado: (2020)

Supplementation with sodium butyrate improves growth and antioxidant function in dairy calves before weaning
por: Liu, Wenhui, et al.
Publicado: (2021)

Effects of Dietary Supplementation with Protected Sodium Butyrate on Gut Microbiota in Growing-Finishing Pigs
por: Bernad-Roche, María, et al.
Publicado: (2021)

The Intestinal Barrier Dysfunction as Driving Factor of Inflammaging
por: Untersmayr, Eva, et al.
Publicado: (2022)

Sodium Butyrate Attenuates Diabetic Kidney Disease Partially via Histone Butyrylation Modification
por: Zhou, Tingting, et al.
Publicado: (2022)

In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Kanuri, Giridhar, et al.
Publicado: (2013)

Effect of sodium butyrate on lymphocyte activation
por: Kyner, D, et al.
Publicado: (1976)

Exenatide Attenuates Non-Alcoholic Steatohepatitis by Inhibiting the Pyroptosis Signaling Pathway
por: Liu, Yu, et al.
Publicado: (2021)

Nutritional Intake and the Risk for Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Schattenberg, Jörn M., et al.
Publicado: (2019)

Effects of Sodium Butyrate Supplementation in Milk on the Growth Performance and Intestinal Microbiota of Preweaning Holstein Calves
por: Wu, Donglin, et al.
Publicado: (2023)

IL-6 Deficiency Attenuates Murine Diet-Induced Non-Alcoholic Steatohepatitis
por: Mas, Emmanuel, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_adcmspm182io6nbt1gm42edqbb